---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290466811.md"
description: "Nuvectis Pharma shares are trading higher after the company announced a strategic portfolio expansion with Haisco Pharmaceutical Group. Also, HC Wainwright & Co raised its price target on the stock from $13 to $39."
datetime: "2026-06-22T17:38:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290466811.md)
  - [en](https://longbridge.com/en/news/290466811.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290466811.md)
generator: "portal-rs"
---

# 

Nuvectis Pharma shares are trading higher after the company announced a strategic portfolio expansion with Haisco Pharmaceutical Group. Also, HC Wainwright & Co raised its price target on the stock from $13 to $39.

### Related Stocks

- [NVCT.US](https://longbridge.com/en/quote/NVCT.US.md)
- [002653.CN](https://longbridge.com/en/quote/002653.CN.md)

## Related News & Research

- [Haisco Enters Into Exclusive License Agreement With New US Venture Founded By Population Health Partners And ARCH Venture Partners](https://longbridge.com/en/news/296910145.md)
- [Nuvectis Pharma sets up $200 million at-the-market equity program with Jefferies](https://longbridge.com/en/news/296650648.md)
- [Heidelberg Pharma says China NMPA clears HDP-101 combo trial in multiple myeloma](https://longbridge.com/en/news/297070749.md)
- [Teva Chief Accounting Officer Amir Weiss sells 9,445 shares for $355,291.07](https://longbridge.com/en/news/297014903.md)
- [Consun Pharmaceutical Declares Interim Cash Dividend for First Half of 2026](https://longbridge.com/en/news/296986586.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**